Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity

ConditionSLE (Systemic Lupus)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAssiut University

About this trial

Assessment of CXCL5 biomarker in Serum of patients of SLE in comparison to healthy patients and its correlation with disease activity

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age >18 years old

Patients who are diagnosed as SLE according to the 2012 Systemic Lupus International Collaborating Clinics (SLICC) Citeria (10,11).

Disqualifiers

age < 18 years old

Patients unwilling to participate in the study.

Patients with other autoimmune diseases.

Patients with malignancy or infections.

Trial population

50 SLE patients and 40 healthy controls

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

blood sampling
Diagnostic test
Blood sample for CXCL5 Level

Treatment groups

90 Participants

are divided into 2 treatment groups

Group A: SLE patients1 intervention

Group B: Healthy controls1 intervention

Trial outcomes

Primary outcomes

To assess CXCL5 level in SLE patients compared to healthy controls

Time frame

2024 -2027

To assess CXCL5 level in association with disease activity

Time frame

2024-2027

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: